Thomas Equels is the President and Chief Executive Officer of AIM ImmunoTech, a biopharmaceutical company headquartered in Ocala, Florida. He leads a team of seasoned professionals dedicated to the clinical development of new drug entities for the treatment of serious and debilitating diseases. Prior to this, Equels had a successful legal career where he focused on complex litigation, particularly on business and commercial matters. He was also a highly decorated combat pilot with the United States Army.
LEGAL CAREER
ARMY CAREER